Skip to main content
Contact Us
Subscribe
E-Edition
69°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novocure Ltd Ord Sh
(NQ:
NVCR
)
14.72
+0.18 (+1.24%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Novocure Ltd Ord Sh
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Novocure to Report Third Quarter 2024 Financial Results
October 01, 2024
From
Novocure
Via
Business Wire
Novocure to Present Real-World Data at ESMO 2024 Demonstrating Improved Survival Outcomes for Newly Diagnosed Glioblastoma Patients with Increased Use of Tumor Treating Fields (TTFields) Therapy
September 09, 2024
From
Novocure
Via
Business Wire
Why NovoCure Stock Dived by 13% This Week
September 06, 2024
Investors found the announced changes to the company's C-suite unsettling.
Via
The Motley Fool
Novocure Announces Planned CEO Transition
September 03, 2024
From
Novocure
Via
Business Wire
Beyond The Numbers: 4 Analysts Discuss NovoCure Stock
July 26, 2024
Via
Benzinga
Breaking Down NovoCure: 4 Analysts Share Their Views
July 02, 2024
Via
Benzinga
A Closer Look at 7 Analyst Recommendations For NovoCure
June 04, 2024
Via
Benzinga
Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
September 03, 2024
Via
Benzinga
Novocure to Participate in 2024 Wells Fargo Healthcare Conference
August 28, 2024
From
Novocure
Via
Business Wire
Unveiling 8 Analyst Insights On NovoCure
May 02, 2024
Via
Benzinga
Novocure Highlights TTFields Therapy in Treatment of Non-Small Cell Lung Cancer at 2024 World Conference on Lung Cancer
August 14, 2024
From
Novocure
Via
Business Wire
Chips, Glorious Chips!
August 07, 2024
Someone's gotta make 'em, and someone's gotta buy 'em.
Via
The Motley Fool
PayPal Posts Upbeat Earnings, Joins Sprouts Farmers Market, Stanley Black & Decker, Phillips 66 And Other Big Stocks Moving Higher On Tuesday
July 30, 2024
Via
Benzinga
NovoCure (NVCR) Q2 2024 Earnings Call Transcript
July 25, 2024
NVCR earnings call for the period ending June 30, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
NVCR Stock Earnings: NovoCure Beats EPS, Beats Revenue for Q2 2024
July 25, 2024
NVCR stock results show that NovoCure beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Novocure Reports Second Quarter 2024 Financial Results
July 25, 2024
From
Novocure
Via
Business Wire
Novocure to Report Second Quarter 2024 Financial Results
July 01, 2024
From
Novocure
Via
Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
June 07, 2024
Via
Benzinga
METIS Phase 3 Clinical Trial Met Primary Endpoint Significantly Delaying Time to Intracranial Progression with Improved Quality of Life Deterioration-Free Survival
June 03, 2024
From
Novocure
Via
Business Wire
Overseas Shipholding, Micron, Squarespace, Incyte And Other Big Stocks Moving Higher On Monday
May 20, 2024
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
May 15, 2024
Via
Benzinga
Double-Up Delights: 7 Stocks Poised to Soar 100% by 2025
May 14, 2024
These stocks to buy are expected to double by 2025 and could turn mundane market returns into something bigger with a willingness to bet.
Via
InvestorPlace
NovoCure (NVCR) Q1 2024 Earnings Call Transcript
May 03, 2024
NVCR earnings call for the period ending March 31, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
NVCR Stock Earnings: NovoCure Beats EPS, Beats Revenue for Q1 2024
May 02, 2024
NVCR stock results show that NovoCure beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Novocure Secures New $400 Million Multi-Tranche Non-Dilutive Debt Financing from Pharmakon
May 02, 2024
From
Novocure
Via
Business Wire
Novocure Reports First Quarter 2024 Financial Results
May 02, 2024
From
Novocure
Via
Business Wire
Results of Novocure’s METIS Phase 3 Clinical Trial for Patients with Brain Metastasis from Non-Small Cell Lung Cancer to be Presented as Late-Breaking Abstract at ASCO 2024
April 24, 2024
From
Novocure
Via
Business Wire
Novocure Announces 20 Presentations On Tumor Treating Fields, Highlighting Preclinical Effects in Pancreatic Cancer and Immune Effects, at American Association for Cancer Research (AACR) Annual Meeting 2024
April 05, 2024
From
Novocure
Via
Business Wire
10 Health Care Stocks Whale Activity In Today's Session
April 03, 2024
Via
Benzinga
Novocure to Report First Quarter 2024 Financial Results
April 01, 2024
From
Novocure
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.